当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析

华东医药

(000963)

  

流通市值:728.53亿  总市值:729.32亿
流通股本:17.52亿   总股本:17.54亿

华东医药(000963)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润27.42亿元,每股收益1.57元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2449633.41万元,未分配利润1857348.61万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3992878.32万元,负债1543244.91万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入32,664,143,135.6821,674,928,965.2110,735,787,899.8241,905,707,385.91
营业总成本29,289,598,185.119,418,419,774.589,620,007,130.4337,493,020,210.87
其他经营收益
营业利润3,350,590,171.042,243,373,665.841,132,257,266.344,324,737,325.9
利润总额3,262,621,550.612,193,163,350.791,104,950,943.824,301,513,879.47
净利润2,741,858,261.191,803,329,008.97913,984,183.423,494,185,631.76
每股收益
其他综合收益83,361,634.4123,756,112.0582,044,972.47-10,256,659.99
综合收益总额2,825,219,895.61,827,085,121.02996,029,155.893,483,928,971.77
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计22,720,785,150.7221,636,328,948.1722,407,223,702.9721,051,790,761.29
非流动资产:
非流动资产合计17,207,998,049.7617,179,119,992.6117,039,935,979.3416,827,255,605.86
资产总计39,928,783,200.4838,815,448,940.7839,447,159,682.3137,879,046,367.15
流动负债:
流动负债合计14,576,398,430.0413,879,308,222.714,351,327,970.2413,794,235,373.01
非流动负债:
非流动负债合计856,050,673.1821,134,219.99533,135,114.07521,056,082.02
负债合计15,432,449,103.1414,700,442,442.6914,884,463,084.3114,315,291,455.03
所有者权益(或股东权益):
归属于母公司股东权益合计24,132,887,034.3123,751,917,39824,059,686,522.6223,060,051,397.36
股东权益合计24,496,334,097.3424,115,006,498.0924,562,696,59823,563,754,912.12
负债和股东权益合计39,928,783,200.4838,815,448,940.7839,447,159,682.3137,879,046,367.15
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计35,850,038,955.9323,360,782,717.9110,114,621,423.5344,970,182,586.26
经营活动现金流出小计33,239,187,011.7520,903,934,207.8110,947,350,117.4141,221,253,703.91
经营活动产生的现金流量净额2,610,851,944.182,456,848,510.1-832,728,693.883,748,928,882.35
投资活动产生的现金流量:
投资活动现金流入小计74,640,978.358,162,534.1653,101,907327,006,060.47
投资活动现金流出小计1,153,032,874.23849,919,602.36698,941,307.412,497,277,729.47
投资活动产生的现金流量净额-1,078,391,895.93-791,757,068.2-645,839,400.41-2,170,271,669
筹资活动产生的现金流量:
筹资活动现金流入小计2,739,973,759.11,937,773,758.021,435,998,8485,250,514,515.6
筹资活动现金流出小计5,102,611,698.723,471,204,956.521,522,837,485.846,000,178,834.72
筹资活动产生的现金流量净额-2,362,637,939.62-1,533,431,198.5-86,838,637.84-749,664,319.12
汇率变动对现金及现金等价物的影响-6,921,970.54-116,843,004.4-3,115,685.5-47,001,718.46
现金及现金等价物净增加额-837,099,861.9114,817,239-1,568,522,417.63781,991,175.77
期末现金及现金等价物余额4,153,051,324.775,004,968,425.683,421,628,769.054,990,151,186.68
补充资料:
现金及现金等价物的净增加额-14,817,239-781,991,175.77
最新报告期:2025-10-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中国银河孙怡,程培2.192.552.852025-10-30
华泰证券代雯,李奕玮2.172.452.722025-10-28
中金公司张琎,朱言音2.252.59--2025-10-28
中信证券宋硕,陈竹2.262.562.882025-10-09
天风证券张雪,杨松2.232.582.922025-09-19
TOP↑